Establishing the acupuncture-moxibustion clinical trial registry and improving the transparence of clinical trials of acupuncture and moxibustion.
- Author:
Yali LIU
1
;
Liyun HE
1
;
Jia LIU
1
;
Xingyue YANG
2
;
Dongning YAN
1
;
Xin WANG
1
;
Lin LUO
1
;
Hongjiao LI
1
;
Shiyan YAN
1
;
Tiancai WEN
1
;
Wenjing BAI
1
;
Taixiang WU
3
;
Baoyan LIU
4
Author Information
- Publication Type:Journal Article
- Keywords: acupuncture-moxibustion; clinical trial registry
- From: Chinese Acupuncture & Moxibustion 2017;37(7):685-689
- CountryChina
- Language:Chinese
- Abstract: As a kind of intervention measures of traditional Chinese medicine, acupuncture-moxibustion is highly adopted on global clinical practice. Even though the global clinical trial registration system was established more than 10 years ago, the proportion of acupuncture-moxibustion clinical trial registration is still very low; and it is very problematic on the methodological quality and report quality in the published acupuncture-moxibustion clinical trials. In order to manage particularly the acupuncture-moxibustion clinical trials, China Academy of Chinese Medical Sciences, collaborated with China Association of Acupuncture and Moxibustion and World Federation of Acupuncture Societies, established the Acupuncture-Moxibustion Clinical Trail Registry (AMCTR). AMCTR is a secondary registry platform affiliated to the Chinese Clinical Trial Registry (ChiCTR) and WHO International Clinical Trials Registry Platform (ICTRP), specifically for the acceptance and management of clinical trials in the field of acupuncture and moxibustion. It is a nonprofit academic organization, located in China Academy of Chinese Medical Sciences.
